CompletedNot Applicable

Comparison Between Ultra-low-dose Computed Tomography and Lung MRI in Cystic Fibrosis

France185 participantsStarted 2021-08-05

Plain-language summary

The purpose of this study is to compare the performances of ultra-low dose computed tomography (CT) and lung magnetic resonance imaging (MRI) for morphological assessment of cystic fibrosis-related lung disease and to compare their performances to conventional low dose CT

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 year-old * Diagnosis of cystic fibrosis provided by genetic and swear test * Chest CT acquisition performed as part of the standard follow-up * Patient with social security or health insurance * Informed consent Exclusion Criteria: * MRI contraindication * Orthopnea * Inability to hold breath for 17 seconds * No spirometry planned the same day * Lung transplant patient

What they're measuring

Reproducibility of visual score between imaging modalities

Timeframe: 1 day

Trial details

NCT IDNCT04644471

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-25

View on ClinicalTrials.gov More Cystic Fibrosis trials